Xylem INC Form 4 insider transactions

D Christian Koch, a Director of Xylem Inc., received 1,247 shares of common stock on August 13, 2026.

Michael J. McGann, EVP & President of MCS at Xylem Inc., reported a stock transaction on July 1, 2026.

Xylem Inc. Director Uday Yadav was awarded 1,711 restricted stock units, aligning his interests with shareholders.

Xylem Inc. Director Lila Tretikov was granted 1,711 restricted stock units valued at $116.88 per share, vesting before the 2027 Annual Meeting.

Director Mark D. Morelli acquired 1,711 restricted stock units of Xylem Inc. as part of an equity incentive plan.

Xylem Inc. Director Robert F. Friel acquired 2,481 shares of common stock via a restricted stock unit award.

Xylem Inc. Director Earl R. Ellis acquired 1,711 restricted stock units as part of an equity incentive plan.

Xylem Inc. SVP and CAO Geri-Michelle McShane exercised stock options and sold shares in a routine transaction.

Xylem Inc.'s SVP, CAO Geri-Michelle McShane, disposed of 64 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Xylem Inc.'s EVP, Claudia S. Toussaint, reported a disposition of 305 common shares to cover tax liabilities related to restricted stock unit vesting.

Xylem Inc.'s EVP & President, WI, Hayati Yarkadas, disposed of 41 common shares to cover tax liabilities related to RSU vesting.

Xylem Inc.'s President and CEO, Matthew F. Pine, disposed of 1,846 shares of common stock to cover tax liabilities related to vested restricted stock units.

Xylem Inc.'s EVP & President, MCS, Michael J. McGann, disposed of 238 shares of common stock to cover tax liabilities related to RSU vesting.

Xylem Inc.'s EVP & Chief Financial Officer, William K. Grogan, reported the withholding of 641 common shares to cover tax obligations related to restricted stock unit vesting.

Meredith Emmerich, EVP & President of Applied Water at Xylem Inc., disposed of 158 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Xylem Inc.'s EVP & Chief Legal Officer, Stacy Cozad, disposed of 70 shares of common stock to cover tax liabilities related to RSU vesting.

Xylem Inc.'s EVP of Strategy, Albert Cho, disposed of 177 shares of common stock to cover tax obligations related to vested restricted stock units.

Xylem Inc. EVP Rodney Aulick reported a routine disposition of 234 common shares to cover tax liabilities from restricted stock unit vesting.

Xylem Inc.'s EVP of Strategy, Albert Cho, acquired common stock and stock options through performance-based vesting and restricted stock awards, while also disposing of shares for tax obligations.

Xylem Inc.'s EVP & President, Michael J. McGann, reported multiple acquisitions of common stock and stock options, primarily from vesting performance-based units and new awards.

Xylem Inc.'s EVP & President, WI, Hayati Yarkadas, reported the vesting of performance-based stock units and the award of new restricted stock units and stock options.

Xylem Inc.'s Senior Vice President and Chief Accounting Officer, Geri-Michelle McShane, reported acquisitions of common stock and stock options, alongside tax-related share dispositions.

Xylem Inc. EVP & President, WSS, Rodney Aulick, disposed of 457 common shares to cover tax liabilities related to RSU vesting.

Xylem Inc. EVP & President Rodney Aulick disposed of 1,840 shares of common stock to cover tax liabilities related to RSU vesting.

Xylem Inc. Director Victoria D. Harker sold 1,700 shares of common stock for approximately $251,838 under a pre-arranged 10b5-1 trading plan.

Xylem Inc.'s EVP, Claudia S. Toussaint, reported the sale of 10,421 shares of common stock from her revocable trust at a weighted average price of $152.64 per share.

Meredith Emmerich, EVP & President of Applied Water at Xylem Inc., is scheduled to dispose of 841 shares of common stock on October 21, 2025, to cover tax liabilities from RSU vesting.

Xylem Inc.'s SVP & Chief Financial Officer, William K. Grogan, disposed of 4,254 shares of common stock on September 18, 2025, to cover tax liabilities from RSU vesting.

Xylem Inc.'s VP, CAO Geri-Michelle McShane reported a pre-planned sale of 1,000 common stock shares at a weighted average price of $139.962.

Xylem Inc.'s SVP & Chief Legal Officer, Stacy Cozad, was granted 735 restricted stock units and 2,579 non-qualified stock options, vesting over three years.